Secondly, our analysis does not include copy number variation analysis or methylation analysis, as some of this variation may be significant in cancer predisposition risk, therefore, prevalence calculations might be slightly underestimated.
← all excerpts
Assessment of pathogenic variation in gynecologic cancer genes in a national cohort.
1
—
—